glycocyamine has been researched along with Myasthenia Gravis in 2 studies
glycocyamine: RN given refers to parent cpd; structure
guanidinoacetate : A monocarboxylic acid anion that is the conjugate base of guanidinoacetic acid, obtained by deprotonation of the carboxy group.
guanidinoacetic acid : The N-amidino derivative of glycine.
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| TORDA, C | 1 |
| WOLFF, HG | 1 |
| BILLIG, HE | 1 |
| MOREHOUSE, LE | 1 |
2 other studies available for glycocyamine and Myasthenia Gravis
| Article | Year |
|---|---|
Glycocyamine elimination in patients with myasthenia gravis.
Topics: Glycine; Humans; Myasthenia Gravis | 1946 |
Performance and metabolic alterations during betaine glycocyamine feeding in myasthenia gravis.
Topics: Betaine; Glycine; Humans; Myasthenia Gravis | 1955 |